Schubert & Co’s Surgery Partners SGRY Stock Holding History

Schubert & Co’s Portfolio SGRY Stock Details SGRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2	Closed	–	–	1579
2022 Q1	$0	Buy	2 +1	+100%	+$49	﹤0.01%	1311
2021 Q4	$0	Buy	+1	New	+$46	﹤0.01%	1257

Other funds holding SGRY

BCI

Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Schubert & Co's SGRY Position: Q2 2022 in Review

Schubert & Co sold out of Surgery Partners (SGRY) in Q2 2022, closing a stake of 2 shares.

Schubert & Co first reported a position in SGRY in Q4 2021 and held it in 2 quarters. The position peaked at $0 in Q1 2022. 137 funds tracked by Wall St. Rank hold SGRY as of Q2 2022.

Schubert & Co reported no remaining Surgery Partners position as of Q2 2022 after selling out during the quarter.
Schubert & Co sold 2 Surgery Partners shares in Q2 2022.
Schubert & Co first reported a position in Surgery Partners in Q4 2021 and held it in 2 quarters.
Schubert & Co's Surgery Partners position peaked at $0 in Q1 2022.
137 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2022.

Based on Schubert & Co's 13F filing for Q2 2022, filed 1 Aug 2022.